| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Ezell Ryan Gillis | CEO, Director | 5775 N. SAM HOUSTON PARKWAY W., STE 400, HOUSTON | /s/ J. Bond Clement as attorney-in-fact | 03 Nov 2025 | 0001805598 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | FTK | Common Shares | Tax liability | -$148K | -7.87K | -5% | $18.75 | 150K | 30 Oct 2025 | Direct | F1 |
| transaction | FTK | Common Shares | Options Exercise | +30K | +20.07% | 180K | 30 Oct 2025 | Direct | F2 | ||
| transaction | FTK | Common Shares | Tax liability | -$221K | -11.8K | -6.58% | $18.75 | 168K | 30 Oct 2025 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | FTK | Performance Based Restricted Stock Unit | Options Exercise | -30K | -100% | 0 | 30 Oct 2025 | Common Stock | 30K | Direct | F2 |
| Id | Content |
|---|---|
| F1 | Includes 526 shares Dr. Ezell acquired under Flotek Industries, Inc.'s 2012 Employee Stock Purchase Plan for the 3-month period commencing July 1, 2025. This transaction is exempt under both Rule 16b-3(d) and Rule 16b-3(c). |
| F2 | Each Performance Based Restricted Stock Unit represents a contingent right to receive one share of Flotek Industries, Inc. common stock subject to achieving a certain threshold on or before December 31, 2025. |